{
    "2018-08-24": [
        [
            {
                "time": "",
                "original_text": "[强烈推荐-A评级]天坛生物(600161)中报点评：小幅上调盈利预测",
                "features": {
                    "keywords": [
                        "强烈推荐",
                        "A评级",
                        "天坛生物",
                        "中报",
                        "盈利预测"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]天坛生物(600161)半年报点评：采浆量稳步提升 渠道优势明显",
                "features": {
                    "keywords": [
                        "增持",
                        "天坛生物",
                        "半年报",
                        "采浆量",
                        "渠道优势"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]天坛生物(600161)中报点评：采浆量增长13.89% 血制品业务实现稳定增长",
                "features": {
                    "keywords": [
                        "增持",
                        "天坛生物",
                        "中报",
                        "采浆量",
                        "血制品",
                        "稳定增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}